VALN Stock Analysis: Buy, Sell, or Hold?

VALN - Valneva SE American Depositary Shares

Biological Products, (No Diagnostic Substances)
$5.07
0.10 (2.01%) ▲
5d: +2.22%
30d: -2.97%
90d: -5.23%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026 9d

Get Alerted When VALN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: VALN shows positive signals but monitor for confirmation. Market pricing in 6.5% decline. Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$8.45
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.25
3.4% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.8x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: VALN is currently trading at $5.07, which is considered fair relative to its 30-day fair value range of $4.93 to $5.25. From a valuation perspective, the stock is trading at a discount (Forward PE: 4.8) compared to its historical average (5.8). Remarkably, the market is currently pricing in an annual earnings decline of 6.5% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, VALN is in a downtrend. The price is approaching resistance at $5.15. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.20 (+145.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $4.93 - $5.25
Company Quality Score 47/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 72.4%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 145.5% below Wall St target ($12.20)

Trading Range Analysis

30-Day Trading Range $4.93 - $5.25
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $4.75
Resistance Level $5.15
Current Trend Downtrend
Technical data as of Aug 3, 2026

Fundamental Context

Forward P/E (Next Year Est.) 4.78
Wall Street Target $12.20 (+145.5%)
Revenue Growth (YoY) -37.2%
Profit Margin -88.3%
Valuation Discount vs History -6.5% cheaper
PE vs Historical 4.8 vs 5.8 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -6.5% (market-implied from PE analysis)
1-Year Target $4.65 (-7%)
2-Year Target $4.34 (-13%)
3-Year Target $4.06 (-18%)
3-Yr Target (if PE normalizes) (PE: 5→6) $4.93 (-1%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 4.8 to 5.8
Stabilization Target: $6.03 (+21.4%)
PE Expansion Potential: +21.4%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 03, 2026 2:49 PM ET
Data refreshes hourly during market hours. Next update: 3:49 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for VALN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$386 43 HOLD
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$89 59 HOLD
RARE
Ultragenyx
STRONG BUY
20 analysts
$53 57 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD
RCKT
Rocket Pharmaceuticals I…
STRONG BUY
18 analysts
$9 57 HOLD

More Analysis for VALN

VALN Technical Chart VALN Price Prediction VALN Earnings Date VALN Investment Advisor VALN Fair Price Analyzer VALN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals